Advertisement

Index by author

April 01, 1987; Volume 241,Issue 1

  1. Dennis, T

    1. Fengabine, a novel antidepressant GABAergic agent. II. Effect on cerebral noradrenergic, serotonergic and GABAergic transmission in the rat.
      B Scatton, K G Lloyd, B Zivkovic, T Dennis, Y Claustre, J Dedek, S Arbilla, S Z Langer and G Bartholini
      Journal of Pharmacology and Experimental Therapeutics April 1987, 241 (1) 251-257;

  2. Depenbusch, J W

    1. Acute regional vascular effects of intravenous captopril in a rat model of myocardial infarction and failure.
      H Drexler, J W Depenbusch, A G Truog, R Zelis and S F Flaim
      Journal of Pharmacology and Experimental Therapeutics April 1987, 241 (1) 13-19;

  3. Depoortere, H

    1. Fengabine, a novel antidepressant GABAergic agent. I. Activity in models for antidepressant drugs and psychopharmacological profile.
      K G Lloyd, B Zivkovic, D Sanger, H Depoortere and G Bartholini
      Journal of Pharmacology and Experimental Therapeutics April 1987, 241 (1) 245-250;

  4. De Rick, A F

    1. Influence of enhanced alpha-1-acid glycoprotein concentration on protein binding, pharmacokinetics and antiarrhythmic effect of lidocaine in the dog.
      A F De Rick, F M Belpaire, C Dello and M G Bogaert
      Journal of Pharmacology and Experimental Therapeutics April 1987, 241 (1) 289-293;

  5. De Wied, D

    1. Structure activity relationship studies with C-terminal fragments of vasopressin and oxytocin on avoidance behaviors of rats.
      D de Wied, O Gaffori, J P Burbach, G L Kovács and J M van Ree
      Journal of Pharmacology and Experimental Therapeutics April 1987, 241 (1) 268-274;

  6. Dijoseph, J F

    1. Gastric antisecretory and antiulcer effects of WHR1582A, a compound exerting alpha-2 adrenoceptor agonist activity.
      J F DiJoseph, J R Eash and G N Mir
      Journal of Pharmacology and Experimental Therapeutics April 1987, 241 (1) 97-102;

  7. Drexler, H

    1. Acute regional vascular effects of intravenous captopril in a rat model of myocardial infarction and failure.
      H Drexler, J W Depenbusch, A G Truog, R Zelis and S F Flaim
      Journal of Pharmacology and Experimental Therapeutics April 1987, 241 (1) 13-19;

  8. Duffy, P

    1. Sensitization to repeated morphine injection in the rat: possible involvement of A10 dopamine neurons.
      P W Kalivas and P Duffy
      Journal of Pharmacology and Experimental Therapeutics April 1987, 241 (1) 204-212;
    2. Mu opioid receptor involvement in enkephalin activation of dopamine neurons in the ventral tegmental area.
      L G Latimer, P Duffy and P W Kalivas
      Journal of Pharmacology and Experimental Therapeutics April 1987, 241 (1) 328-337;

  9. Eash, J R

    1. Gastric antisecretory and antiulcer effects of WHR1582A, a compound exerting alpha-2 adrenoceptor agonist activity.
      J F DiJoseph, J R Eash and G N Mir
      Journal of Pharmacology and Experimental Therapeutics April 1987, 241 (1) 97-102;

  10. Eva, C

    1. Changes of cholinergic, noradrenergic and serotonergic synaptic transmission indices elicited by ethylcholine aziridinium ion (AF64A) infused intraventricularly.
      C Eva, M Fabrazzo and E Costa
      Journal of Pharmacology and Experimental Therapeutics April 1987, 241 (1) 181-186;
« Previous (Pages : 1 2 3 4 5 6 7 8 9 10 ... 19) Next »
Back to top

In this issue

Advertisement